Last day to apply for a postdoctoral position at the Vall d'Hebron Institute of Oncology (VHIO) @vhio.bsky.social. Visit or web and contact us for your next training position in cancer research! malumbreslab.org vhiovidaprogramme.eu
Marcos Malumbres
@mmalumbres.bsky.social
Cancer cell biologist at ICREA, @vhio.bsky.social, @irbbarcelona.org & visiting @danafarber.bsky.social. Collaborating with AECC, SOLTI, FERO and @ASEICA.bsky.social. Love all arts, from python to books, music and painting. malumbreslab.org
Se va acercando la Trobada de Alcoi. Este año centrada en el cáncer y el estilo de vida. La inscripción es gratuita y hay premios a las mejores presentaciones. Más información en este link: www.trailsolidarialcoi.org/inici-trobad...
📍¿Conoces la Campaña "Ayuda a salvar vidas" de @Erumgroup y ASEICA? 📽️https://www.youtube.com/watch?v=Me2A2r40shM Por cada baliza vendida: 10€ para investigación Puedes comprarla aquí: 📷
La baliza v16 que salva vidas | ASEICA y LEDONE contra el cáncer
Por cada compra de la baliza v16 destinamos 10€ de forma íntegra a la investigación contra el cáncer de la asociación ASEICA.
ledone.eco
A new paper on microplastics accumulating in the brain was just published in Nature Medicine. I've reviewed the background and main findings in a new Ground Truths post erictopol.substack.com/p/the-microp...
Delighted our work using aneuploidy as a biomarker of colorectal cancer risk in inflammatory bowel disease is out: gut.bmj.com/content/earl... The initial reaction from patients&families has been overwhelming Led by Ibrahim AlBakir @yosoykit.bsky.social @cancerresearchuk.org @icrlondon.bsky.social
Low-coverage whole genome sequencing of low-grade dysplasia strongly predicts advanced neoplasia risk in ulcerative colitis
Background The risk of developing advanced neoplasia (AN; colorectal cancer and/or high-grade dysplasia) in ulcerative colitis (UC) patients with a low-grade dysplasia (LGD) lesion is variable and dif...
gut.bmj.com
Some of the LLLMs and exciting efforts briefly reviewed and linked
Cuatro personas que denunciaron a María Blasco han aceptado relatar su experiencia a EL PAÍS. Entre los denunciantes hay jefes, directores, investigadores, becarios. Al menos cinco son mujeres. “La imagen de María es limpia de puertas afuera, pero de puertas adentro es terrible”
Hablan los denunciantes de acoso en el CNIO: “No hay miedo a María Blasco, hay terror”
elpais.com
Two internal reports alert to the decline of @cniostopcancer.bsky.social and hold its director, María Blasco, responsible. There are multiple complaints against Blasco for harassment, mistreatment and abuse of power #oncosky @nunodomin.bsky.social @cienciagob.bsky.social @saludisciii.bsky.social 🧪
Dos informes internos alertan al Ministerio de Ciencia del declive del CNIO y responsabilizan a su directora, María Blasco
Los documentos hablan de múltiples denuncias contra la bióloga por acoso, maltrato y abuso de poder. La producción científica del mayor centro de cáncer de España se desmorona
elpais.com
Please, help the CNIO! @cniostopcancer.bsky.social @cienciagob.bsky.social @saludisciii.bsky.social #oncosky #oncsky 🧪
Please, help the CNIO! @cniostopcancer.bsky.social @cienciagob.bsky.social @saludisciii.bsky.social #oncosky #oncsky 🧪
La petición de cambio de la Dirección Científica del CNIO por 24 Jefes de Investigación tiene que resolverse ya. Por respeto a la institución y al proceso en marcha, no me he manifestado antes. Pero “Alemania nazi, genocidio…” inaguantable elpais.com/ciencia/2025...
All the #NatureReviews journals and Nature Protocols are now on Bluesky, lots of Editors added to the starter pack too if you want to follow us 🧪 go.bsky.app/KcxvQLp
@amit25.bsky.social: El 50% de los Jefes de Investigación del CNIO (la mitad mujeres), hemos solicitado un proceso de recambio de la dirección científica del centro. Esta petición está basada en argumentos contrastables que de ninguna manera incluyen un componente de género. @cienciagob.bsky.social
Ante las acusaciones públicas vertidas en las últimas semanas contra nuestra socia, María Blasco, directora científica del CNIO, AMIT ha hecho público el siguiente comunicado: amit-es.org/noticias/ant...
The VIDA COFUND Postdoctoral Programme is now open at @vhio.bsky.social . Please visit vhiovidaprogramme.eu for more info and join any of our #cancer #research laboratories in Barcelona! #oncosky #medsky 🧪 malumbreslab.org
Follow our #SLCL starter pack for more news on #lung #cancer #oncosky #oncsky 🧪
Our @sosclc-aecc.bsky.social researcher @crismayorruiz.bsky.social reports a new therapeutic strategy against #lung #cancer. A perfect example of the ideas to be developed within the #SCLC network! #oncosky #oncsky 🧪
Interested in cancer research @vhio.bsky.social? Check out this list and let me know if anyone is missing! bsky.app/profile/did:...
Announcing the new bioRxiv dashboard widget - it's now easier to when articles have comments, peer reviews, community discussion, media coverage, videos, and automated analyses 1/2 connect.biorxiv.org/news/2025/01...
This is amazing!!! @caldaslab.bsky.social is excited about this approach to study cancer xenograft models!
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - Nature Biotechnology
An integrated experimental and deep learning pipeline reveals cell-level targeting of nanocarriers in whole bodies.
nature.com
A paper in Nature presents an AI model that can translate speech and text, including direct speech-to-speech translations, for up to 101 languages. The model, named SEAMLESSM4T, fills gaps in language coverage and outperforms existing systems. 🧪
Joint speech and text machine translation for up to 100 languages - Nature
SEAMLESSM4T is a single machine translation tool that supports speech-to-speech translation, speech-to-text translation, text-to-speech translation, text-to-text translation and automatic speech recognition between up to 100 languages.
go.nature.com
The VIDA COFUND Postdoctoral Programme is now open at @vhio.bsky.social . Please visit vhiovidaprogramme.eu for more info and join any of our #cancer #research laboratories in Barcelona! #oncosky #medsky 🧪 malumbreslab.org
Open call for a Junior Group Leader position in #ComputationalOncology at Vall d'Hebron Institute of Oncology (VHIO) @vhio.bsky.social. See details below and consider applying jobs.vhio.net/en/jobs/5412... #CancerResearch
2024-081-01 Junior Group Leader - VHIO
Under the leadership of Josep Tabernero, VHIO is an internationally recognized cancer center. Its multidisciplinary, collaborative model drives scientific progress and innovative cancer treatments.
jobs.vhio.net
Amazing data to advance discovery and use of cancer biomarkers…
very happy to share our latest preprint, led by Michaela Unger: www.biorxiv.org/content/10.1... We are using Deep Learning to improve the detection of biomarkers in cancer genomic data 👇 This is an emerging field, much more to come.
I am thrilled to finally share our work on persister cancer cells: we identify distinctive features and actionable #vulnerabilities ⚡️of persister cancer cells (#DTP), and provide mechanistic insight into their low #inflammatory activity: aacrjournals.org/cancerres/ar...
H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells
Cell persistence and senescence are distinct states of proliferative arrest induced by cancer therapy, with persister cells being characterized by the silencing of inflammatory genes through the heter...
aacrjournals.org
Feliç any nou! Amb els millors desitjos per a 2025 💫 ¡Feliz año nuevo! Con los mejores deseos para 2025 💫 Happy New Year! Wishing you the very best for 2025 💫
Our lab malumbreslab.org @vhio.bsky.social will join CIBERONC in 2025. Thanks for counting on us!! www.ciberonc.es/en
El @ciccancer.bsky.social contará con nuevo laboratorio especializado en la investigación de resistencia a tratamientos de cáncer que será dirigido por Mónica Álvarez Fernández se incorporará como investigadora principal www.cicancer.org/science-soci...